Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul;17(7):52.
doi: 10.1007/s11920-015-0591-z.

Assessment and treatment of anxiety disorders in children and adolescents

Anna M Wehry  1 , Katja Beesdo-Baum, Meghann M Hennelly, Sucheta D Connolly, Jeffrey R Strawn
Affiliations
Review

Assessment and treatment of anxiety disorders in children and adolescents

Anna M Wehry et al. Curr Psychiatry Rep. 2015 Jul.

Abstract

Recent advances in the developmental epidemiology, neurobiology, and treatment of pediatric anxiety disorders have increased our understanding of these conditions and herald improved outcomes for affected children and adolescents. This article reviews the current epidemiology, longitudinal trajectory, and neurobiology of anxiety disorders in youth. Additionally, we summarize the current evidence for both psychotherapeutic and psychopharmacologic treatments of fear-based anxiety disorders (e.g., generalized, social, and separation anxiety disorders) in children and adolescents. Current data suggest that these disorders begin in childhood and adolescence, exhibit homotypic continuity, and increase the risk of secondary anxiety and mood disorders. Psychopharmacologic trials involving selective serotonin reuptake inhibitors (SSRIs) and selective serotonin norepinephrine reuptake inhibitors (SSNRIs) are effective in pediatric patients with anxiety disorders and have generally demonstrated moderate effect sizes. Additionally, current data support cognitive behavioral therapy (CBT) for the treatment of these conditions in youth and suggest that the combination of psychotherapy + an SSRI may be associated with greater improvement than would be expected with either treatment as monotherapy.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1. The age of onset distribution of (A) anxiety, depressive and substance use disorders and (B) specific anxiety disorders at age 33, and estimated cumulative incidence rates at age 33 (in parenthesis)
Data from the Early Developmental Stages of Psychopathology (EDSP) Study. Adapted from [8].
FIGURE 2
FIGURE 2. Structures and regions implicated in pediatric patients with fear-based anxiety disorders
The cuneus (yellow), precuneus (light green), dorsal anterior cingulate (red), pre/subgenual anterior cingulate (purple) and ventromedial prefrontal cortex (light blue) are show medially in A, while the ventrolateral prefrontal cortex (VLPFC, lime green) is shown in the left lateral view in B. Adapted from [28].
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169–84. - PMC - PubMed
    1. Merikangas KR, He JP, Burnstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication—Adolescent Supplement (NCS-A) J Am Acad Child Adolesc Psychiatry. 2010;49(10):980–9. - PMC - PubMed
    1. Foley DL, Goldston DB, Costello EJ, Angold A. Proximal psychiatric rick factors for suicidality in youth: the Great Smoky Mountains study. Arch Gen Psychiatry. 2006;63:1017–1024. - PubMed
    1. Jacobson CM, Muehlenkamp JJ, Miller AL, Turner JB. Psychiatric impairment among adolescents engaging in different types of deliberate self-harm. J Clin Child Adolesc Psychol. 2008;37(2):363–75. - PubMed
    1. Beesdo-Baum K, Pine DS, Lieb R, Wittchen J. Mental disorders in adolescence and young adulthood: homotypic and heterotypic longitudinal associations. American College of Neuropsychopharmacology 51st Annual Meeting; Hollywood, Florida. 2012.

MeSH terms